Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Crispr Therapeutics AG (CRSP) Technical Analysis

5,883 Followers

Summary of all the Indicators

Summary
Strong Buy
14Bullish
6Neutral
2Bearish
Oscillators
Buy
4Bullish
6Neutral
0Bearish
Moving Averages
Strong Buy
10Bullish
0Neutral
2Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is 3.80, suggesting Crispr Therapeutics AG is a Buy.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 61.21, while Crispr Therapeutics AG’s (CRSP) share price is $64.66, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 55.79, while Crispr Therapeutics AG’s (CRSP) share price is $64.66, making it a Buy.

Crispr Therapeutics AG (CRSP) Pivot Points

May 27, 2023, 11:37 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
57.50
59.83
61.84
64.17
66.18
68.51
70.52
Fibonacci
59.83
61.49
62.51
64.17
65.83
66.85
68.51

Crispr Therapeutics AG (CRSP) Moving Averages

May 27, 2023, 11:37 PM
Period
Simple
Exponential
MA5
65.48Sell
64.78Sell
MA10
64.50Buy
63.99Buy
MA20
60.87Buy
61.21Buy
MA50
52.57Buy
55.79Buy
MA100
51.10Buy
53.77Buy
MA200
54.81Buy
57.22Buy
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 63.99, while Crispr Therapeutics AG’s (CRSP) share price is $64.66, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 53.77, while Crispr Therapeutics AG’s (CRSP) share price is $64.66, making it a Buy.
Crispr Therapeutics AG’s (CRSP) stock price is $64.66 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 52.57, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) stock price is $64.66 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 51.10, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) stock price is $64.66 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 54.81, creating a Buy signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

May 27, 2023, 11:37 PM
Name
Value
Action
RSI (14)
60.02
Neutral
STOCH (9,6)
36.37
Neutral
STOCHRSI (14)
58.59
Neutral
MACD (12,26)
3.80
Buy
ADX (14)
41.01
Neutral
Williams %R
-45.09
Buy
CCI (14)
43.18
Neutral
ATR (14)
3.78
-
Ultimate Oscillator
46.77
Neutral
ROC
15.55
Buy
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 60.02, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 41.01, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is 43.18, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is 15.55, creating a Buy signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Strong Buy.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 60.02, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is 3.80, which suggests CRSP is a Buy.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 65.48, which suggests CRSP is a Sell.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 60.87, which suggests CRSP is a Buy.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 52.57, which suggests CRSP is a Buy.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 54.81, which suggests CRSP is a Buy.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -45.09, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is 43.18, which suggests CRSP is a Neutral.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis